Ironwood Pharmaceuticals, Inc.
IRWD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $212,502 | $115,988 | $236,632 | $708,335 |
| - Cash | $140,407 | $92,852 | $108,481 | $88,559 |
| + Debt | $213,240 | $601,889 | $599,081 | $599,481 |
| Enterprise Value | $285,335 | $625,025 | $727,232 | $1,219,257 |
| Revenue | $122,060 | $85,239 | $41,143 | $90,545 |
| % Growth | 43.2% | 107.2% | -54.6% | – |
| Gross Profit | $122,060 | $85,239 | $13,711 | $90,545 |
| % Margin | 100% | 100% | 33.3% | 100% |
| EBITDA | $76,929 | $46,645 | -$10,070 | $33,394 |
| % Margin | 63% | 54.7% | -24.5% | 36.9% |
| Net Income | $40,080 | $23,599 | -$37,386 | $2,256 |
| % Margin | 32.8% | 27.7% | -90.9% | 2.5% |
| EPS Diluted | 0.23 | 0.14 | -0.23 | 0.014 |
| % Growth | 64.3% | 160.9% | -1,731.2% | – |
| Operating Cash Flow | $47,583 | -$15,068 | $19,954 | $15,214 |
| Capital Expenditures | -$2 | -$2 | -$31 | $0 |
| Free Cash Flow | $47,581 | -$15,070 | $19,923 | $15,214 |